Benign Mesothelial Proliferations of the Tunica Vaginalis Testis
Abstract
:1. Introduction
2. Case Studies
2.1. Case 1
2.2. Case 2
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Churg, A.; Colby, T.V.; Cagle, P.; Corson, J.; Gibbs, A.R.; Gilks, B.; Grimes, M.; Hammar, S.; Roggli, V.; Travis, W.D. The separation of benign and malignant mesothelial proliferations. Am. J. Surg. Pathol. 2000, 24, 1183–1200. [Google Scholar] [CrossRef] [PubMed]
- Fletcher, C.D.M. Diagnostic Histopathology of Tumors, 5th ed.; Elsevier: Amsterdam, The Netherlands, 2020. [Google Scholar]
- Chekol, S.S.; Sun, C.C. Malignant mesothelioma of the tunica vaginalis testis. Diagnostic studies and differential diagnosis. Arch. Pathol. Lab. Med. 2012, 136, 113–117. [Google Scholar] [CrossRef] [PubMed]
- Lee, S.; Illei, P.B.; Han, J.S.; Epstein, J.I. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma. A clinicopathologic study of 12 cases. Am. J. Surg. Pathol. 2014, 38, 54–59. [Google Scholar] [CrossRef] [PubMed]
- Butnor, K.J.; Pavlisko, E.N.; Sporn, T.A.; Roggli, V.L. Mesothelioma of the tunica vaginalis testis. Hum. Pathol. 2019, 92, 48–58. [Google Scholar] [CrossRef]
- Attanoos, R.L.; Griffin, A.; Gibbs, A.R. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2. Histopathology 2003, 43, 231–238. [Google Scholar] [CrossRef] [PubMed]
- Kato, Y.; Tsuta, K.; Seki, K.; Maeshima, A.M.; Watanabe, S.; Suzuki, K.; Asamura, H.; Tsuchiya, R.; Matsuno, Y. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod. Pathol. 2007, 20, 215–220. [Google Scholar] [CrossRef]
- Lagana, S.M.; Taub, R.N.; Borczuk, A.C. Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions. Arch. Pathol. Lab. Med. 2012, 136, 804–809. [Google Scholar] [CrossRef]
- Lee, A.F.; Gown, A.M.; Churg, A. IMP3 and GLUT-1 immunohistochemistry for distinguishing benign from malignant mesothelial proliferations. Am. J. Surg. Pathol. 2013, 37, 421–426. [Google Scholar] [CrossRef]
- Cigognetti, M.; Lonardi, S.; Fisogni, S.; Balzarini, P.; Pellegrini, V.; Tironi, A.; Bercich, L.; Bugatti, M.; Rossi, G.; Murer, B.; et al. BAP-1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod. Pathol. 2015, 28, 1043–1057. [Google Scholar] [CrossRef]
- Mlika, M.; Zorgati, M.; BenKhelil, M.; El-Mezni, F. About the diagnostic value of BAP-1 antibody in malignant pleural mesothelioma: A meta-analysis. J. Immunoass. Immunochem. 2019, 40, 269–282. [Google Scholar] [CrossRef]
- Takeda, M.; Kasai, T.; Enomoto, Y.; Takano, M.; Morita, K.; Kadota, E.; Ilzuka, N.; Maruyama, H.; Nonomura, A. Genomic gains and losses in malignant mesothelioma demonstrated by FISH analysis of paraffin-embedded tissues. J. Clin. Pathol. 2012, 65, 77–82. [Google Scholar] [CrossRef] [PubMed]
- Churg, A. Paratesticular mesothelial proliferations. Sem. Diagn. Pathol. 2003, 20, 272–278. [Google Scholar] [CrossRef] [PubMed]
- Al-Obaidy, K.I.; Alruwaii, F.I.; Ulbright, T.M.; Idrees, M.T. Appendageal tumors and tumor-like lesions of the testis and paratestis: A 32-year experience at a single institution. Hum. Pathol. 2020, 103, 25–33. [Google Scholar] [CrossRef] [PubMed]
- Brimo, F.; Illei, P.B.; Epstein, J.I. Mesothelioma of the tunica vaginalis: A series of eight cases with uncertain malignant potential. Mod. Pathol. 2010, 23, 1165–1172. [Google Scholar] [CrossRef] [PubMed]
- Chetty, R. Well differentiated (benign) papillary mesothelioma of the tunica vaginalis. J. Clin. Pathol. 1992, 45, 1029–1030. [Google Scholar] [CrossRef]
- Galateau-Sallé, F.; Vignaud, J.M.; Burke, L.; Gibbs, A.; Brambilla, E.; Attanoos, R.; Goldberg, M.; Launoy, G. Well-differentiated papillary mesothelioma of the pleura. A series of 24 cases. Am. J. Surg. Pathol. 2004, 28, 534–540. [Google Scholar] [CrossRef]
- Tolhurst, S.R.; Lotan, T.; Rapp, D.E.; Lyon, M.B.; Orvieto, M.A.; Gerber, G.S.; Sokoloff, M.H. Well-differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis with contralateral atypical mesothelial hyperplasia. Urol. Oncol. 2006, 24, 36–39. [Google Scholar] [CrossRef]
- Chen, X.; Sheng, W.; Wang, J. Well-differentiated papillary mesothelioma: A clinicopathological and immunohistochemical study of 18 cases with additional observation. Histopathology 2013, 62, 805–813. [Google Scholar] [CrossRef]
- Tan, W.K.; Tan, M.Y.; Tan, W.S.; Gan, S.C.; Pathmanathan, R.; Tan, H.M.; Tan, W.P. Well-differentiated papillary mesothelioma of the tunica vaginalis: Case report and systematic review of literature. Clin. Genitourin. Cancer 2017, 15, 463–471. [Google Scholar] [CrossRef]
- Cutts, R.; Connor, M.J.; Sun, L.; Johnston, T.; Gooch, R.; McLoughlin, J. Mesothelioma subtypes of the tunica vaginalis: A rare case report and review of histological criteria. J. Surg. Case Rep. 2019, 3, 1–3. [Google Scholar] [CrossRef]
- Ordoñez, N.G. Value of calretinin immunostaining in diagnostic pathology: A review and update. Appl. Immunohistochem. Mol. Morphol. 2014, 22, 401–415. [Google Scholar] [CrossRef] [PubMed]
- King, J.E.; Thatcher, N.; Pickering, C.A.C.; Hasleton, P.S. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: A detailed systematic analysis using published data. Histopathology 2006, 48, 223–232. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Manini, C.; López-Fernández, E.; Cruciano, N.; Comandone, A.; López, J.I. Benign Mesothelial Proliferations of the Tunica Vaginalis Testis. Clin. Pract. 2023, 13, 1130-1136. https://doi.org/10.3390/clinpract13050101
Manini C, López-Fernández E, Cruciano N, Comandone A, López JI. Benign Mesothelial Proliferations of the Tunica Vaginalis Testis. Clinics and Practice. 2023; 13(5):1130-1136. https://doi.org/10.3390/clinpract13050101
Chicago/Turabian StyleManini, Claudia, Estíbaliz López-Fernández, Nicola Cruciano, Alessandro Comandone, and José I. López. 2023. "Benign Mesothelial Proliferations of the Tunica Vaginalis Testis" Clinics and Practice 13, no. 5: 1130-1136. https://doi.org/10.3390/clinpract13050101
APA StyleManini, C., López-Fernández, E., Cruciano, N., Comandone, A., & López, J. I. (2023). Benign Mesothelial Proliferations of the Tunica Vaginalis Testis. Clinics and Practice, 13(5), 1130-1136. https://doi.org/10.3390/clinpract13050101